Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evelyn Tuma

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Human Immunology|December 14, 2002
Plasmacytoid dendritic cells: the key to CpGSimon Rothenfusser, Evelyn Tuma, Stefan Endres, et al.
Current Opinion in Molecular Therapeutics|May 30, 2003
Recent advances in immunostimulatory CpG oligonucleotidesSimon Rothenfusser, Evelyn Tuma, Moritz Wagner, et al.
European Journal of Immunology|January 31, 2003
Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapyKlaus Heckelsmiller, Sebastian Beck, Katharina Rall, et al.
The Journal of Investigative Dermatology|November 26, 2002
Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseasesAndreas Wollenberg, Moritz Wagner, Sandra Günther, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNAMoritz Wagner, Hendrik Poeck, Bernd Jahrsdoerfer, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Human Immunology|December 14, 2002
Plasmacytoid dendritic cells: the key to CpGSimon Rothenfusser, Evelyn Tuma, Stefan Endres, et al.
Current Opinion in Molecular Therapeutics|May 30, 2003
Recent advances in immunostimulatory CpG oligonucleotidesSimon Rothenfusser, Evelyn Tuma, Moritz Wagner, et al.
European Journal of Immunology|January 31, 2003
Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapyKlaus Heckelsmiller, Sebastian Beck, Katharina Rall, et al.
The Journal of Investigative Dermatology|November 26, 2002
Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseasesAndreas Wollenberg, Moritz Wagner, Sandra Günther, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNAMoritz Wagner, Hendrik Poeck, Bernd Jahrsdoerfer, et al.
Pageof 1